hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang上一页:癫痫症状 如何护理癫痫患者?
下一页:癫痫会遗传吗 癫痫的治疗方法
- 2022-05-022013年该协会抗癫痫联合会抗癫痫药使用指南
- 2022-04-25治疗儿童癫痫的移植手术方式有哪些
- 2022-04-13控制癫痫患者再次抽搐,不包括可选药物?
- 2022-04-12PLoS ONE:新的合成蛋白能快速激活免疫系统抵抗流感
- 2022-04-11【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 2022-04-11预测癫痫患者再入院风险
- PLoS ONE:新的合成蛋白能快速激活免疫系统抵抗流感
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 预测癫痫患者再入院风险
- Medpage Today:不同类型的抗癫痫药物更有利
- FDA批准Aptiom用于治疗患者癫痫发作
- 英国竞争监管机构指控辉瑞癫痫药品价格过高
- FDA批准开浦兰治疗1个月至4岁癫痫儿童
- 2016AAN:神经专家发表了有前途的专业见解
- 综述:癫痫持续状态诊治最新进展
- 月经期间要注意 有些药物和食物不能食用
- 如何用科学的方法治疗癫痫?
- 癫痫治疗障碍仍难以克服
- 第四届全国临床脑电图实践基础理论与实践操作培训班
- 黑芝麻的营养价值 吃黑芝麻的好处
- 癫痫猝死:凶手是谁?
- 儿童癫痫的早期症状 癫痫的原因
- 手术学习:颅内脊索瘤内镜下三脑室入路治疗
- 癫痫患者手术评估新型工具
- 癫痫发作的症状是什么?
- UCB的Vimpat癫痫新适应症在美国获批
- Circ Ep:左室肥厚高血压患者新发房颤增加SCD风险
- 癫痫会遗传吗 癫痫的治疗方法
- 2013国际抗癫痫联合会抗癫痫药用指南
- 癫痫症状 如何护理癫痫患者?
- 治疗癫痫 治疗癫痫偏方大全
- 心率多少正常 如何保持正常心率不变
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 英国竞争管制机构控诉辉瑞公司癫痫药品价格过高
- 良药良性癫痫病有什么症状
- 难治性癫痫病怎么完成治疗
- 海绵状血管瘤手术切除后可以情况下生活吗?
- 世界癫痫日 | 科学防治 规范诊疗 再会癫痫
- 老年人癫痫病的发病症状
- 癫痫病的症状有哪些 有这症状则否
- 阿尔茨海默病或是人类特有疾病,同神经元及神经环路活性精神状态相关
- 北京:1月20日起无偿献血者临床用血费用单独减免
- 怎么疗法癫痫病
- 癫痫病的罕见症状是什么样
- 人类记忆究竟如何形成及提取?时至今日最清晰证据出现!
- 小儿癫痫的肺癌症状有哪些